The complexity of sterile drug development has been on the rise, which is driven by a variety of different factors. Complex formulation trends are being driven by the industries focus on: Download this white paper to learn more about: Orphan drugs: This market is projected to grow at 13% CAGR from 2020-2024 mRNA therapeutics: Prior to the COVID-19 Pandemic, the global mRNA therapeutics market was estimated to reach ~3B by 2026 Repurposed drugs: Costs of bringing a repurposed drug to market have been estimated to be US$300 million on average, compared with an estimated ~$2–3 billion for a new chemical entity
*In addition, if you want more information or have any questions, please feel free to fill out our Contact Us form and someone will reach out to you shortly.
